UNSW researchers are using e-health to investigate ways to help cancer survivors access treatment for fear of cancer recurrence.
Despite a commitment from the pharmaceutical industry to improve data transparency, more than half of the clinical trials that led to the USFDA approving anticancer medicines over the past 10 years are not available for independent scrutiny.
A Peter Mac-led trial has found that combination PET/CT scans are better at investigating the causes of prolonged fever in blood cancer patients than conventional CT scans.
QIMR Berghofer has signed an agreement with Proteomics allowing the company to develop and commercialise a blood test for early detection of oesophageal cancer.
A clinical trial will use a new strategy to target a 'defence switch' on cancer cells that alerts cancer to the threat of chemotherapy.
Skin cancers account for the largest number of newly diagnosed cancers in Australia each year, with incidence of skin cancers being one of the highest in the world.
A patient's perspective on their physical well-being can provide a better indication of their response to cancer treatment than clinician-based tools.
The University of South Australia and Ferronova are developing a novel technology to precisely image aggressive brain cancers and guide treatment.
Adults aged 45 to 64 experienced a nearly doubled rate of esophageal cancer and a 50% increase in the precancerous condition Barrett’s esophagus between 2012 and 2019, according to a US study.
Professor Trevor Leong, President, TROG Cancer Research, has been awarded the inaugural NHMRC David Cooper Clinical Trials and Cohort Studies Award.
Monash University's registry-based clinical trial, PROpatient, aims to determine if symptom monitoring and care coordination, using digital patient pathways, improve quality of life for cancer patients.
The minimally invasive Ivor Lewis esophagectomy surgery has been successfully performed on a patient at Mater Private Hospital Townsville.
A new Peter Mac-led study has posthumously tested samples from ovarian cancer patients who missed the chance for genetic testing before they died of the disease.
A new study suggests that overdiagnosis, or the finding of tumours that may never have progressed or caused harm in a woman's lifetime, occurs in about 15% of screen-detected cancers.
A new non-invasive treatment for inoperable early-stage liver cancer is set to be trialled across Australia this year.